Jonathan J. Cherry

592 total citations
18 papers, 426 citations indexed

About

Jonathan J. Cherry is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Jonathan J. Cherry has authored 18 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Jonathan J. Cherry's work include Neurogenetic and Muscular Disorders Research (12 papers), RNA modifications and cancer (10 papers) and Cervical Cancer and HPV Research (4 papers). Jonathan J. Cherry is often cited by papers focused on Neurogenetic and Muscular Disorders Research (12 papers), RNA modifications and cancer (10 papers) and Cervical Cancer and HPV Research (4 papers). Jonathan J. Cherry collaborates with scholars based in United States, Italy and Germany. Jonathan J. Cherry's co-authors include Elliot J. Androphy, James Baleja, Matthew C. Evans, Yuqi Liu, Gregory D. Cuny, V. Jo Davisson, Marcie A. Glicksman, Jason J. Chen, Hua Gao and Marc C. Nicklaus and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Jonathan J. Cherry

18 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan J. Cherry United States 14 281 144 124 65 64 18 426
Wenke Weidemann Germany 12 455 1.6× 38 0.3× 95 0.8× 25 0.4× 43 0.7× 16 537
Luciane Sussuchi da Silva Brazil 11 192 0.7× 81 0.6× 29 0.2× 76 1.2× 38 0.6× 31 363
Véronique Leblanc Canada 11 278 1.0× 61 0.4× 40 0.3× 68 1.0× 14 0.2× 15 419
Sheetal A. Raithatha Canada 11 358 1.3× 31 0.2× 28 0.2× 44 0.7× 22 0.3× 17 523
Emanuela Pesce Italy 14 192 0.7× 39 0.3× 64 0.5× 23 0.4× 39 0.6× 38 532
Hong Bae Jeon South Korea 9 273 1.0× 46 0.3× 40 0.3× 37 0.6× 13 0.2× 19 346
Stefanie Enzenmüller Germany 10 250 0.9× 48 0.3× 104 0.8× 52 0.8× 12 0.2× 15 392
Ames C. Register United States 8 146 0.5× 15 0.1× 46 0.4× 26 0.4× 44 0.7× 10 278
Hoa Truong United States 4 122 0.4× 36 0.3× 76 0.6× 20 0.3× 16 0.3× 8 288

Countries citing papers authored by Jonathan J. Cherry

Since Specialization
Citations

This map shows the geographic impact of Jonathan J. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Cherry more than expected).

Fields of papers citing papers by Jonathan J. Cherry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Cherry. The network helps show where Jonathan J. Cherry may publish in the future.

Co-authorship network of co-authors of Jonathan J. Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Cherry. A scholar is included among the top collaborators of Jonathan J. Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Cherry. Jonathan J. Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hinckley, Christopher A., Zhonghua Zhu, J Chu, et al.. (2023). Functional evaluation of epilepsy‐associated KCNT1 variants in multiple cellular systems reveals a predominant gain of function impact on channel properties. Epilepsia. 64(8). 2126–2136. 8 indexed citations
2.
Li, Yanjie, Jixue Li, Jun Wang, et al.. (2021). Targeting 3′ and 5′ untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression. Nucleic Acids Research. 49(20). 11560–11574. 18 indexed citations
3.
Osman, Erkan Y., Rachel Kline, Jonathan J. Cherry, et al.. (2019). Intraperitoneal delivery of a novel drug‐like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy. Scientific Reports. 9(1). 1633–1633. 6 indexed citations
4.
Choi, Sung‐Woon, Hongxia Li, Jonathan J. Cherry, et al.. (2017). Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers. Bioorganic & Medicinal Chemistry Letters. 27(23). 5144–5148. 3 indexed citations
5.
Gopalsamy, Ariamala, Arjun Narayanan, Shenping Liu, et al.. (2017). Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA). Journal of Medicinal Chemistry. 60(7). 3094–3108. 14 indexed citations
6.
Li, Hongxia, Jonathan J. Cherry, Christian L. Lorson, et al.. (2017). Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry. 60(11). 4594–4610. 14 indexed citations
7.
Abera, Mahlet, Jingbo Xiao, Steve Titus, et al.. (2016). ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice. JCI Insight. 1(19). e88427–e88427. 18 indexed citations
8.
Cherry, Jonathan J., Dione Kobayashi, Francesco Danilo Tiziano, et al.. (2014). Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy. Assay and Drug Development Technologies. 12(6). 315–341. 23 indexed citations
9.
Cherry, Jonathan J., et al.. (2013). Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function. PLoS ONE. 8(12). e84506–e84506. 74 indexed citations
10.
Cherry, Jonathan J., Erkan Y. Osman, Matthew C. Evans, et al.. (2013). Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds. EMBO Molecular Medicine. 5(7). 1103–1118. 36 indexed citations
11.
Cherry, Jonathan J., Matthew C. Evans, Jake Ni, et al.. (2012). Identification of Novel Compounds That Increase SMN Protein Levels Using an Improved SMN2 Reporter Cell Assay. SLAS DISCOVERY. 17(4). 481–495. 20 indexed citations
12.
Cherry, Jonathan J. & Elliot J. Androphy. (2012). Therapeutic Strategies For The Treatment Of Spinal Muscular Atrophy. Future Medicinal Chemistry. 4(13). 1733–1750. 14 indexed citations
13.
Evans, Matthew C., Jonathan J. Cherry, & Elliot J. Androphy. (2011). Differential regulation of the SMN2 gene by individual HDAC proteins. Biochemical and Biophysical Research Communications. 414(1). 25–30. 17 indexed citations
14.
Xiao, Jingbo, Juan Marugán, Wei Zheng, et al.. (2011). Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators. Journal of Medicinal Chemistry. 54(18). 6215–6233. 32 indexed citations
15.
Liu, Yuqi, et al.. (2009). Determinants of Stability for the E6 Protein of Papillomavirus Type 16. Journal of Molecular Biology. 386(4). 1123–1137. 25 indexed citations
16.
Wilson, Patricia G., Jonathan J. Cherry, Allison Adams, et al.. (2007). An SMA Project Report: Neural Cell-Based Assays Derived from Human Embryonic Stem Cells. Stem Cells and Development. 16(6). 1027–1042. 13 indexed citations
17.
Cherry, Jonathan J., et al.. (2007). Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT. Journal of Virology. 82(1). 71–76. 32 indexed citations
18.
Baleja, James, Jonathan J. Cherry, Zhiguo Liu, et al.. (2006). Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Research. 72(1). 49–59. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenke Weidemann Breakdown of academic impact, for papers by Luciane Sussuchi da Silva Breakdown of academic impact, for papers by Véronique Leblanc Breakdown of academic impact, for papers by Sheetal A. Raithatha Breakdown of academic impact, for papers by Emanuela Pesce Breakdown of academic impact, for papers by Hong Bae Jeon Breakdown of academic impact, for papers by Stefanie Enzenmüller Breakdown of academic impact, for papers by Ames C. Register Breakdown of academic impact, for papers by Hoa Truong
Rankless by CCL
2026